Caricamento...
Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
Since its approval for the first-line treatment of metastatic colorectal cancer (mCRC), bevacizumab has become a standard treatment option in combination with chemotherapy for patients with mCRC. Bevacizumab has demonstrated efficacy in combination with a number of different backbone chemotherapy re...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AlphaMed Press
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3336830/ https://ncbi.nlm.nih.gov/pubmed/22477726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|